SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-20-001244
Filing Date
2020-05-15
Accepted
2020-05-15 16:01:52
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clcs_10q.htm 10-Q 371156
2 EX-10.49 clcs_ex1049.htm EX-10.49 71395
3 EX-10.50 clcs_ex1050.htm EX-10.50 48644
4 EX-31 clcs_ex31.htm EX-31 9183
5 EX-32 clcs_ex32.htm EX-32 3065
  Complete submission text file 0001640334-20-001244.txt   2235822

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clcs-20200331.xml EX-101.INS 299338
7 XBRL TAXONOMY EXTENSION SCHEMA clcs-20200331.xsd EX-101.SCH 41632
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20200331_lab.xml EX-101.LAB 207564
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20200331_cal.xml EX-101.CAL 14091
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20200331_pre.xml EX-101.PRE 174575
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20200331_def.xml EX-101.DEF 120798
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 20884835
SIC: 2834 Pharmaceutical Preparations